Search

Your search keyword '"Shi, Zhumei"' showing total 35 results
Start Over Author "Shi, Zhumei" Search Limiters Full Text Publication Year Range Last 50 years
35 results on '"Shi, Zhumei"'

5. SREBP2 maintains glioblastoma stem cells through keeping the balance between cholesterol biosynthesis and uptake

Author

Gu, Danling, primary, Zhou, Fengqi, additional, You, Hao, additional, Gao, Jiancheng, additional, Kang, Tao, additional, Dixit, Deobrat, additional, Wu, Qiulian, additional, Yang, Kailin, additional, Ci, Shusheng, additional, Shan, Danyang, additional, Fan, Xiao, additional, Yuan, Wei, additional, Zhang, Qian, additional, Lu, Chenfei, additional, Li, Daqi, additional, Zhao, Ningwei, additional, Shi, Zhumei, additional, Gao, Wei, additional, Lin, Fan, additional, Man, Jianghong, additional, Wang, Qianghu, additional, Qian, Xu, additional, Mack, Stephen C, additional, Tao, Weiwei, additional, Agnihotri, Sameer, additional, Zhang, Nu, additional, You, Yongping, additional, Rich, Jeremy N, additional, Zhang, Junxia, additional, and Wang, Xiuxing, additional

Published
2023
Full Text
View/download PDF

8. PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma

Author

Zhao, Mengjie, primary, Li, Yanhui, additional, Lu, Chenfei, additional, Ding, Fangshu, additional, Xu, Miao, additional, Ge, Xin, additional, Li, Mengdie, additional, Wang, Zhen, additional, Yin, Jianxing, additional, Zhang, Junxia, additional, Wang, Xiefeng, additional, Ge, Zehe, additional, Xiao, Hong, additional, Xiao, Yong, additional, Liu, Hongyi, additional, Liu, Wentao, additional, Cao, Yuandong, additional, Wang, Qianghu, additional, You, Yongping, additional, Wang, Xiuxing, additional, Yang, Kun, additional, Shi, Zhumei, additional, and Qian, Xu, additional

Published
2023
Full Text
View/download PDF

14. β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages

Author

Li, Daqi, primary, Zhang, Qian, additional, Li, Lu, additional, Chen, Kexin, additional, Yang, Junlei, additional, Dixit, Deobrat, additional, Gimple, Ryan C., additional, Ci, Shusheng, additional, Lu, Chenfei, additional, Hu, Lang, additional, Gao, Jiancheng, additional, Shan, Danyang, additional, Li, Yangqing, additional, Zhang, Junxia, additional, Shi, Zhumei, additional, Gu, Danling, additional, Yuan, Wei, additional, Wu, Qiulian, additional, Yang, Kailin, additional, Zhao, Linjie, additional, Qiu, Zhixin, additional, Lv, Deguang, additional, Gao, Wei, additional, Yang, Hui, additional, Lin, Fan, additional, Wang, Qianghu, additional, Man, Jianghong, additional, Li, Chaojun, additional, Tao, Weiwei, additional, Agnihotri, Sameer, additional, Qian, Xu, additional, Shi, Yu, additional, You, Yongping, additional, Zhang, Nu, additional, Rich, Jeremy N., additional, and Wang, Xiuxing, additional

Published
2022
Full Text
View/download PDF

21. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1

Author

Qian, Xu, primary, Li, Xinjian, additional, Shi, Zhumei, additional, Xia, Yan, additional, Cai, Qingsong, additional, Xu, Daqian, additional, Tan, Lin, additional, Du, Linyong, additional, Zheng, Yanhua, additional, Zhao, Dan, additional, Zhang, Chuanbao, additional, Lorenzi, Philip L., additional, You, Yongping, additional, Jiang, Bing-Hua, additional, Jiang, Tao, additional, Li, Haitao, additional, and Lu, Zhimin, additional

Published
2019
Full Text
View/download PDF

27. Role and mechanism of miR-222 in arsenic-transformed cells for inducing tumor growth

Author

Wang, Min, primary, Ge, Xin, additional, Zheng, Jitai, additional, Li, Dongmei, additional, Liu, Xue, additional, Wang, Lin, additional, Jiang, Chengfei, additional, Shi, Zhumei, additional, Qin, Lianju, additional, Liu, Jiayin, additional, Yang, Hushan, additional, Liu, Ling-Zhi, additional, He, Jun, additional, Zhen, Linlin, additional, and Jiang, Bing-Hua, additional

Published
2016
Full Text
View/download PDF

28. GSK-3β regulates tumor growth and angiogenesis in human glioma cells

Author

Zhao, Peng, primary, Li, Qi, additional, Shi, Zhumei, additional, Li, Charlie, additional, Wang, Lin, additional, Liu, Xue, additional, Jiang, Chengfei, additional, Qian, Xu, additional, You, Yongping, additional, Liu, Ning, additional, Liu, Ling-Zhi, additional, Ding, Lianshu, additional, and Jiang, Bing-Hua, additional

Published
2015
Full Text
View/download PDF

30. Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer

Author

Shen, Hua, primary, Zhu, Fang, additional, Liu, Jinyuan, additional, Xu, Tongpeng, additional, Pei, Dong, additional, Wang, Rong, additional, Qian, Yingying, additional, Li, Qi, additional, Wang, Lin, additional, Shi, Zhumei, additional, Zheng, Jitai, additional, Chen, Qiudan, additional, Jiang, Binghua, additional, and Shu, Yongqian, additional

Published
2014
Full Text
View/download PDF

31. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras

Author

Shi, Zhumei, primary, Chen, Qiudan, additional, Li, Chongyong, additional, Wang, Lin, additional, Qian, Xu, additional, Jiang, Chengfei, additional, Liu, Xue, additional, Wang, Xiefeng, additional, Li, Hai, additional, Kang, Chunsheng, additional, Jiang, Tao, additional, Liu, Ling-Zhi, additional, You, Yongping, additional, Liu, Ning, additional, and Jiang, Bing-Hua, additional

Published
2014
Full Text
View/download PDF

34. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Author

Wang X, Huang L, Xu Y, Shi Z, Wang Y, Zhang J, Wang X, Cao L, Luo H, Chen J, Liu N, Yin Y, and You Y

Subjects
Alleles, Asian People genetics, Case-Control Studies, Confidence Intervals, Ethnicity genetics, Gene Frequency, Genetic Heterogeneity, Genotype, Humans, Neoplasms ethnology, Odds Ratio, Risk Factors, Sensitivity and Specificity, Survivin, Inhibitor of Apoptosis Proteins genetics, Neoplasms genetics, Polymorphism, Genetic, Promoter Regions, Genetic
Abstract

Survivin is an inhibitor of apoptosis protein and has a crucial role in the development of cancer. The survivin -31G>C (rs9904341) promoter polymorphism influences survivin expression and has been implicated in cancer risk. However, conflicting results have been published from studies on the association between survivin -31G>C polymorphism and the risk of cancer. To clarify the role of this polymorphism in cancer, we performed a meta-analysis of all available and relevant published studies, involving a total of 3485 cancer patients and 3964 control subjects. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the associations. The overall results indicated that the variant genotypes were associated with a significantly increased cancer risk (CC vs GG: OR=1.58, 95% CI=1.20-2.10; CC/GC vs GG: OR=1.23, 95% CI=1.00-1.51; CC vs GG/GC: OR=1.51, 95% CI=1.23-1.85). In the stratified analyses, significantly increased risk was associated with the Asian populations (CC vs GG: OR=1.67, 95% CI=1.16-2.40; CC vs GG/GC: OR=1.50, 95% CI=1.17-1.91). We also performed the analyses by cancer type, and no statistical association was observed. The results suggest that the survivin -31G>C promoter polymorphism might be associated with an increased risk of cancer, especially in the Asian populations.

Published
2012
Full Text
View/download PDF

35. Updated meta-analysis of NFkappaB1 -94ins/Delattg promoter polymorphism and cancer risk based on 19 case-control studies.

Author

Wang X, Lu P, Xu L, Xu Y, Shi Z, Xu J, Wang Y, Zhang J, Wang X, Cao L, Liu N, Yin Y, and You Y

Subjects
Case-Control Studies, Gene Frequency, Genotype, Humans, INDEL Mutation, Polymorphism, Single Nucleotide, Risk Factors, Genetic Predisposition to Disease, NF-kappa B genetics, Neoplasms genetics, Promoter Regions, Genetic genetics
Abstract

Objective: Recently, a common insertion/deletion (-94insertion/deletion ATTG, rs28362491) polymorphism in the NFkappaB1 promoter region has been extensively investigated for association with cancer risk but the results have been inconsistent. In order to clarify the effect of the promoter polymorphism we performed an update meta-analysis of published case-control studies to better compare the results between studies., Methods: Relevant studies were identified via a thorough literature search on Medline and Embase database (up to August 10, 2011). The odds ratio (OR) and 95% confidence interval (95%CI) were used to investigate the strength of the association., Results: A total of 5,196 cases and 6,614 controls in 19 case-control studies from 16 publications were included in this meta-analysis. Overall, the variant genotypes were associated with a moderately decreased risk of all cancer types (OR =0.74, 95%CI =0.57-0.97 for DD versus II; OR =0.79, 95%CI =0.66-0.95 for DD versus II/ID). In the stratified analyses, significantly decreased risk was found among Asians (OR =0.52, 95%CI =0.42-0.65 for DD versus II; OR =0.74, 95%CI =0.66-0.83 for ID versus II; OR =0.64, 95%CI =0.53-0.78 for DD versus II/ID; OR =0.68, 95%CI =0.61-0.75 for DD/ID versus II). The validity of this association was further strengthened by the sensitivity analysis. No publication bias was observed in this study., Conclusions: Our results suggested that the -94deletion ATTG promoter polymorphism in NFkappaB1 gene might be associated with a decreased cancer risk, especially for Asian population.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results